GlassScriptPhysician profile
Douglas A Matey
NPI 1801095831
$2,890.87
in general payments reported to CMS, 2019-2025
18 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $223 · 2021: $102 · 2022: $1,171 · 2023: $99.62 · 2024: $764 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588 · Travel and Lodging: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.74 |
| Travel and Lodging | $408.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,976.47 | 2019-2025 | Real Intelligence, Journey II, Tandem |
| Stryker Corporation | $234.84 | 2022-2025 | Triathlon |
| Depuy Synthes Sales INC. | $109.88 | 2019-2024 | Orthovisc, Monovisc |
| Medtronic USA, INC. | $83.28 | 2019 | |
| Horizon Therapeutics Plc | $78.82 | 2019-2020 | |
| Kci USA, INC. | $63.72 | 2019-2021 | |
| Alafair Biosciences, INC. | $45.72 | 2022 | |
| Radius Health, INC. | $44.86 | 2019 | |
| Pacira Therapeutics, INC. | $44.58 | 2020-2021 | |
| Heron Therapeutics, INC. | $35.37 | 2021-2022 | |
| Medical Device Business Services, INC. | $34.00 | 2020 | |
| Aroa Biosurgery Incorporated | $31.69 | 2024 | |
| Sanofi-Aventis U.S. LLC | $23.81 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $22.19 | 2020 | |
| Orthofix Medical, INC. | $18.75 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15.15 | 2020 | |
| Arthrosurface Incorporated | $14.07 | 2019 | |
| Baudax Bio INC. | $13.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Matey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.